ribavirin has been researched along with ascorbic acid in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.25) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (37.50) | 29.6817 |
| 2010's | 7 (43.75) | 24.3611 |
| 2020's | 2 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Abdalla, MM; Farghaly, TA | 1 |
| Abdalla, MM; Abdel Hafez, NA; Awad, HM; Farghaly, TA; Ragab, EA | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Andrei, G; Cazin, I; Harej, A; Klobučar, M; Macan, AM; Pavelić, K; Pavelić, SK; Raić-Malić, S; Schols, D; Snoeck, R; Stepanić, V | 1 |
| Chang, TW; Snydman, DR | 1 |
| Hara, Y; Hino, K; Kawakami, T; Kitase, A; Murakami, Y; Nagai, A; Okita, K; Okita, M; Okuda, M | 1 |
| Furutani, T; Hara, Y; Hino, K; Kitase, A; Murakami, Y; Nagai, A; Okita, K; Okita, M; Okuda, M; Ren, F; Yamaguchi, Y; Yamashita, S; Yutoku, K | 1 |
| Kakibuchi, N; Kawakami, T; Kawashima, A; Kita, K; Koyabu, T; Murakami, Y; Okita, M; Takaguchi, K | 1 |
| Kakibuchi, N; Kawakami, T; Kawashima, A; Kita, K; Koyabu, T; Murakami, Y; Okita, M; Takaguchi, K; Tsukamoto, I | 1 |
| Ball, M; Duan, S; Gu, L; Guli, L; Lu, J; Wang, Y; Yin, J; Zheng, R | 1 |
| Cai, C; Cui, X; Guo, W; He, S; Wang, J; Xu, Y; Zhang, T; Zhao, X; Zheng, G; Zheng, J | 1 |
| Albreem, MA; Alomari, OA; Alsharif, MH; Alsharif, YH; Hossain, MS; Jahid, A; Solyman, AAA; Yahya, K | 1 |
3 review(s) available for ribavirin and ascorbic acid
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Antiviral agents: action and clinical use.
Topics: Amantadine; Antiviral Agents; Ascorbic Acid; Cytarabine; Humans; Idoxuridine; Influenza, Human; Inosine Pranobex; Interferons; Levamisole; Methisazone; Ribavirin; Vidarabine; Virus Replication | 1979 |
Application of machine intelligence technology in the detection of vaccines and medicines for SARS-CoV-2.
Topics: Adenosine Monophosphate; Alanine; Antibodies, Monoclonal, Humanized; Antiviral Agents; Artificial Intelligence; Ascorbic Acid; Chloroquine; COVID-19; COVID-19 Drug Treatment; COVID-19 Vaccines; Deep Learning; Drug Combinations; Drug Development; Drug Repositioning; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lopinavir; Machine Learning; Ribavirin; Ritonavir; Vitamins | 2020 |
3 trial(s) available for ribavirin and ascorbic acid
| Article | Year |
|---|---|
Vitamin E and C supplementation prevents decrease of eicosapentaenoic acid in mononuclear cells in chronic hepatitis C patients during combination therapy of interferon alpha-2b and ribavirin.
Topics: Alanine Transaminase; Antiviral Agents; Ascorbic Acid; Dietary Supplements; Drug Synergism; Drug Therapy, Combination; Eicosapentaenoic Acid; Fatty Acids, Unsaturated; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Leukocytes, Mononuclear; Male; Middle Aged; Recombinant Proteins; Ribavirin; Treatment Outcome; Viral Load; Vitamin E; Vitamins | 2006 |
Alpha-tocopherol [corrected] and ascorbic acid attenuates the ribavirin [corrected] induced decrease of eicosapentaenoic acid in erythrocyte membrane in chronic hepatitis C patients.
Topics: alpha-Tocopherol; Ascorbic Acid; Drug Therapy, Combination; Eicosapentaenoic Acid; Erythrocyte Membrane; Female; Hepatitis C, Chronic; Humans; Liver Function Tests; Male; Middle Aged; Ribavirin; Treatment Outcome | 2006 |
Zinc supplementation prevents the increase of transaminase in chronic hepatitis C patients during combination therapy with pegylated interferon alpha-2b and ribavirin.
Topics: Alanine Transaminase; Antiviral Agents; Ascorbic Acid; Carnosine; Dietary Supplements; Drug Therapy, Combination; Fatty Acids, Unsaturated; Female; Flow Cytometry; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Organometallic Compounds; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Thiobarbituric Acid Reactive Substances; Time Factors; Transaminases; Treatment Outcome; Vitamin E; Vitamins; Zinc; Zinc Compounds | 2007 |
10 other study(ies) available for ribavirin and ascorbic acid
| Article | Year |
|---|---|
Synthesis, tautomerism, and antimicrobial, anti-HCV, anti-SSPE, antioxidant, and antitumor activities of arylazobenzosuberones.
Topics: Animals; Anti-Bacterial Agents; Antineoplastic Agents; Antioxidants; Antiviral Agents; Azo Compounds; Biphenyl Compounds; Cricetinae; Hepacivirus; Hydrazones; Inhibitory Concentration 50; Magnetic Resonance Spectroscopy; Mass Spectrometry; Mice; Microbial Sensitivity Tests; Neoplasms, Experimental; Picrates; Spectrophotometry, Infrared; SSPE Virus | 2009 |
Synthesis, anti-HCV, antioxidant, and peroxynitrite inhibitory activity of fused benzosuberone derivatives.
Topics: Animals; Antioxidants; Antiviral Agents; Biphenyl Compounds; Brain; Cricetinae; Hepacivirus; Heterocyclic Compounds, 2-Ring; Microbial Sensitivity Tests; Peroxynitrous Acid; Picrates; Pyridines; Replicon; Viral Nonstructural Proteins | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Antitumor and antiviral activities of 4-substituted 1,2,3-triazolyl-2,3-dibenzyl-L-ascorbic acid derivatives.
Topics: Antineoplastic Agents; Antiviral Agents; Apoptosis; Ascorbic Acid; Cell Proliferation; Cells, Cultured; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Triazoles; Viruses | 2019 |
Eicosapentaenoic acid supplementation for chronic hepatitis C patients during combination therapy of pegylated interferon alpha-2b and ribavirin.
Topics: Alanine Transaminase; Antiviral Agents; Ascorbic Acid; Dietary Supplements; Drug Therapy, Combination; Eicosapentaenoic Acid; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Vitamin E | 2008 |
Regulation of influenza virus-caused oxidative stress by Kegan Liyan oral prescription, as monitored by ascorbyl radical ESR signals.
Topics: Animals; Antioxidants; Antiviral Agents; Ascorbic Acid; Biomarkers; Down-Regulation; Drugs, Chinese Herbal; Electron Spin Resonance Spectroscopy; Female; Free Radicals; Influenza A virus; Lung; Magnoliopsida; Male; Mice; Mice, Inbred Strains; Orthomyxoviridae Infections; Oxidation-Reduction; Oxidative Stress; Phytotherapy; Pneumonia, Viral; Ribavirin; Superoxide Dismutase | 2009 |
Detectable SARS-CoV-2 viral RNA in feces of three children during recovery period of COVID-19 pneumonia.
Topics: Ascorbic Acid; Betacoronavirus; Biomarkers; Ceftriaxone; Child; China; Clinical Laboratory Techniques; Convalescence; Coronavirus Infections; COVID-19; COVID-19 Testing; Drugs, Chinese Herbal; Feces; Humans; Interferons; Male; Pandemics; Patient Discharge; Pharynx; Pneumonia, Viral; Reverse Transcriptase Polymerase Chain Reaction; Ribavirin; RNA, Viral; SARS-CoV-2; Tomography, X-Ray Computed | 2020 |